Bourne N - Search Results

1

Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.

Ishikawa T, Wang G, Widman DG, Infante E, Winkelmann ER, Bourne N, Mason PW. Ishikawa T, et al. Among authors: bourne n. Vaccine. 2011 Oct 6;29(43):7444-55. doi: 10.1016/j.vaccine.2011.07.058. Epub 2011 Jul 26. Vaccine. 2011. PMID: 21798299

2

Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen.

Gu B, Ouzunov S, Wang L, Mason P, Bourne N, Cuconati A, Block TM. Gu B, et al. Among authors: bourne n. Antiviral Res. 2006 Jun;70(2):39-50. doi: 10.1016/j.antiviral.2006.01.005. Antiviral Res. 2006. PMID: 16724398

3

Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivo.

Rossi SL, Fayzulin R, Dewsbury N, Bourne N, Mason PW. Rossi SL, et al. Among authors: bourne n. Virology. 2007 Jul 20;364(1):184-95. doi: 10.1016/j.virol.2007.02.009. Epub 2007 Mar 23. Virology. 2007. PMID: 17382364 Free article.

4

Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production.

Bourne N, Scholle F, Silva MC, Rossi SL, Dewsbury N, Judy B, De Aguiar JB, Leon MA, Estes DM, Fayzulin R, Mason PW. Bourne N, et al. J Virol. 2007 Sep;81(17):9100-8. doi: 10.1128/JVI.00316-07. Epub 2007 Jun 13. J Virol. 2007. PMID: 17567689 Free PMC article.

5

Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system.

Widman DG, Ishikawa T, Fayzulin R, Bourne N, Mason PW. Widman DG, et al. Among authors: bourne n. Vaccine. 2008 May 23;26(22):2762-71. doi: 10.1016/j.vaccine.2008.03.009. Epub 2008 Mar 31. Vaccine. 2008. PMID: 18423946

6

Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis.

Ishikawa T, Widman DG, Bourne N, Konishi E, Mason PW. Ishikawa T, et al. Among authors: bourne n. Vaccine. 2008 May 23;26(22):2772-81. doi: 10.1016/j.vaccine.2008.03.010. Epub 2008 Mar 31. Vaccine. 2008. PMID: 18433947

7

Antiviral activity of geneticin against dengue virus.

Zhang XG, Mason PW, Dubovi EJ, Xu X, Bourne N, Renshaw RW, Block TM, Birk AV. Zhang XG, et al. Among authors: bourne n. Antiviral Res. 2009 Jul;83(1):21-7. doi: 10.1016/j.antiviral.2009.02.204. Epub 2009 Mar 11. Antiviral Res. 2009. PMID: 19501253 Free PMC article.

8

RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters.

Widman DG, Ishikawa T, Winkelmann ER, Infante E, Bourne N, Mason PW. Widman DG, et al. Among authors: bourne n. Vaccine. 2009 Sep 18;27(41):5550-3. doi: 10.1016/j.vaccine.2009.07.016. Epub 2009 Jul 25. Vaccine. 2009. PMID: 19635608

9

Estradiol improves genital herpes vaccine efficacy in mice.

Pennock JW, Stegall R, Bell B, Vargas G, Motamedi M, Milligan G, Bourne N. Pennock JW, et al. Among authors: bourne n. Vaccine. 2009 Sep 25;27(42):5830-6. doi: 10.1016/j.vaccine.2009.07.052. Epub 2009 Aug 4. Vaccine. 2009. PMID: 19660586 Free PMC article.

10

Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis.

Fischer NO, Infante E, Ishikawa T, Blanchette CD, Bourne N, Hoeprich PD, Mason PW. Fischer NO, et al. Among authors: bourne n. Bioconjug Chem. 2010 Jun 16;21(6):1018-22. doi: 10.1021/bc100083d. Bioconjug Chem. 2010. PMID: 20509624 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters